ERBB2 and neoplasm: For instance, SDC is an aggressive tumour characterized by overexpression of androgen receptor in 80-90% of cases, HER2 overexpression with higher variability (16-83%), and PI3KCA, HRAS, and BRAF mutations in a lower rate (92).